Clinical Trial Update: Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in Korea [Phase 4]

View source ↗

Summary

A Phase 4 study in Korea comparing tiotropium plus fluticasone propionate/salmeterol versus tiotropium alone evaluates clinical outcomes in chronic obstructive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Advair (fluticasone propionate/salmeterol)
• Spiriva (tiotropium)

Snippet

Sponsor: The Korean Academy of Tuberculosis and Respiratory Diseases | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED